Publications by authors named "Youzhao Ma"

Claim this Profile
P
Prognostic significance of HER2-low and HER2-zero status before and after neoadjuvant chemotherapy in patients with HER2-negative breast cancer.
Youzhao Ma, Jingyang Zhang, Lina Wang, Dechuang Jiao, Xiuchun Chen

Ther Adv Med Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study.
Youzhao Ma, Mingda Zhu, Jingyang Zhang, Dechuang Jiao, Yangyang Hou

Breast· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy.
Youzhao Ma, Jingyang Zhang, Dechuang Jiao, Xiuchun Chen, Zhenzhen Liu

Cancer Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer.
Youzhao Ma, Dechuang Jiao, Jingyang Zhang, Minhao Lv, Xiuchun Chen

Oncologist· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy.
Youzhao Ma, Mingda Zhu, Jingyang Zhang, Minhao Lv, Xiuchun Chen

Cancer Res Treat· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of residual disease biomarkers on the prognosis of HER2-positive breast cancer following neoadjuvant therapy.
Youzhao Ma, Mingda Zhu, Minhao Lv, Peng Yuan, Xiuchun Chen

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy.
Youzhao Ma, Minhao Lv, Peng Yuan, Xiuchun Chen, Zhenzhen Liu

BMC Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database.
Junzhao Wu, Minhao Lv, Peng Yuan, Youzhao Ma, Peiqi Tian

Gland Surg· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Marital Status on Prognosis of Patients With Invasive Breast Cancer: A Population-Based Study Using SEER Database.
Dechuang Jiao, Youzhao Ma, Jiujun Zhu, Hao Dai, Yue Yang

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
Minhao Lv, Juntao Li, Huihui Guo, Chao Wang, Peiqi Tian, Youzhao Ma

Ann Surg Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Min-Hao Lyu, You-Zhao Ma, Pei-Qi Tian, Hui-Hui Guo, Chao Wang

Chin Med J (Engl)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
Minhao Lv, Juntao Li, Huihui Guo, Chao Wang, Peiqi Tian, Youzhao Ma

Ann Surg Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of whether adjuvant chemotherapy can be safely omitted for older female patients with ER-positive, HER2-negative N1 breast cancer: a study based on the SEER database.
Minhao Lv, Peng Yuan, Youzhao Ma, Peiqi Tian, Xiuchun Chen

Ann Transl Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Youzhao Ma, Jingyang Zhang, Xiuchun Chen

Cancer Manag Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant docetaxel with or without carboplatin plus dual HER2 blockade for HER2-positive breast cancer: a retrospective multi-center Chinese study.
Minhao Lv, Huihui Guo, Chao Wang, Peiqi Tian, Youzhao Ma

Gland Surg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors and prognostic value of pathologic complete response of ipsilateral supraclavicular lymph nodes in breast cancer after neoadjuvant chemotherapy.
Jiujun Zhu, Dechuang Jiao, Xuhui Guo, Jianghua Qiao, Youzhao Ma

Ann Transl Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis